16/01/2024
WhiteLab Genomics and Siren Biotechnology Announce Strategic Partnership to Accelerate AI-Powered Advancements in Gene Therapy
WhiteLab Genomics and Siren Biotechnology to engage in a strategic partnership to develop an AI-powered indication discovery platform for AAV...
En savoir plus
31/10/2023 / News
Former Chief Strategy Officer at Sanofi, Laurent van Lerberghe Joins WhiteLab Genomics Board of Directors
Paris, France & Boston, USA - October 31, 2023: WhiteLab Genomics is excited to introduce Laurent van Lerberghe, the former...
En savoir plus
23/10/2023 / News
Sanofi, WhiteLab Genomics, the TaRGeT Laboratory at Nantes University, and Institut Imagine launch WIDGeT to make France a global leader in gene therapy.
Sanofi, WhiteLab Genomics, the TaRGeT Laboratory at Nantes University, and Institut Imagine launch WIDGeT to make France a global...
En savoir plus
06/10/2023 / News
Exploring Quebec’s Highly Innovative Ecosystem: A Promising Business Mission
At the end of September, the "Mission entreprises " was jointly organized by the Île-de-France Region and Business France...
En savoir plus
18/08/2023 / News
WhiteLab Genomics is a finalist for The Galien Foundation « Best Startup » category!
We are honored to be a finalist for The Galien Foundation "Best Startup" category alongside so many inspiring companies! ...
En savoir plus
22/07/2023 / News
Novel machine learning protocol for the phenotypic prediction of AAV variants library production
Whitelab Genomics is pleased to present the poster that we had the privilege of unveiling at ASGCT 2023.
En savoir plus
18/06/2023 / News
WhiteLab Genomics is a laureate of the French Tech 2030 program!
WhiteLab Genomics is honored to be part of the FrenchTech2030 Promotion! The program set up aims to provide...
En savoir plus
27/03/2023 / News
WhiteLab Genomics is a laureate of the first French Tech Health20 class!
WhiteLab Genomics is a laureate of the first French Tech Health20 class! The French Tech Health20 is a...
En savoir plus
12/10/2022 / News
Investment fuels AI-driven development of breakthrough genomic medicines
David Del Bourgo (CEO and co-founder, Whitelab Genomics) has always been passionate about introducing disruptive, innovative technologies to markets. Now,...
En savoir plus